Life Science REIT PLC Working Capital to Net Assets Ratio
Life Science REIT PLC working capital to net assets ratio. Life Science REIT PLC (LABS) has a Working Capital to Net Assets ratio of 0.0% as of June 2024. Working capital of GBX5.00K (current assets of GBX10.51 Million minus current liabilities of GBX10.51 Million) is measured against net assets of GBX267.23 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Life Science REIT PLC (2021–2023)
Working capital to net assets ratio of Life Science REIT PLC from 2021 to 2023. This chart shows how Life Science REIT PLC's Working Capital to Net Assets ratio has evolved across 3 annual periods from 2021 to 2023. As of June 2024, the ratio stands at 0.0%, reflecting working capital of GBX5.00K against net assets of GBX267.23 Million GBX. Explore long-term investment intensity of Life Science REIT PLC to see how much of total assets are deployed in long-term investments.
Life Science REIT PLC Working Capital to Net Assets Ratio by Year (2021–2023)
Life Science REIT PLC working capital to net assets ratio by year from 2021 to 2023. The table below presents the year-by-year Working Capital to Net Assets ratio for Life Science REIT PLC from 2021 to 2023, covering 3 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see LABS total assets.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 4.4% | GBX12.52 Million | GBX283.75 Million | GBX14.34 Million | GBX1.82 Million | ▼ -1.8 pp |
| 2022 | 6.2% | GBX19.95 Million | GBX319.45 Million | GBX20.97 Million | GBX1.03 Million | ▼ -40.9 pp |
| 2021 | 47.2% | GBX165.42 Million | GBX350.58 Million | GBX166.94 Million | GBX1.52 Million | — |